CIK: 0001822947 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $95,991 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 70,000 | $9,440 | 9.8% | $134.85 | — | SPONSORED ADS | 00370M103 |
| IVA | INVENTIVA SA | 1,500,000 | $6,975 | 7.3% | $4.65 | — | ADS | 46124U107 |
| NERV | MINERVA NEUROSCIENCES INC | 1,655,500 | $6,655 | 6.9% | $3.71 | 0.0% | COM NEW | 603380205 |
| EWTX | EDGEWISE THERAPEUTICS INC | 250,000 | $6,204 | 6.5% | $20.07 | 0.0% | PUT | 28036F105 |
| PRAX | PRAXIS PRECISION MEDICINES I | 19,882 | $5,860 | 6.1% | $186.22 | 0.0% | COM NEW | 74006W207 |
| EWTX | EDGEWISE THERAPEUTICS INC | 195,000 | $4,839 | 5.0% | $20.07 | 0.0% | COM | 28036F105 |
| QURE | UNIQURE NV | 200,000 | $4,786 | 5.0% | — | — | CALL | N90064101 |
| OVID | OVID THERAPEUTICS INC | 1,785,000 | $2,910 | 3.0% | $1.54 | 0.0% | COM | 690469101 |
| TSHA | TAYSHA GENE THERAPIES INC | 500,000 | $2,750 | 2.9% | $2.83 | +71.5% | CALL | 877619106 |
| PMN | PROMIS NEUROSCIENCES INC | 249,339 | $1,702 | 1.8% | $9.76 | 0.0% | COM SHS | 74346M505 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | 250,000 | $16,900 | 17.6% | $65.05 | -15.7% | CALL | 834203309 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 32,662 | $14,981 | 15.6% | $373.08 | +36.9% | — | 558868105 |
| ASND | ASCENDIS PHARMA A/S - ADR | 51,080 | $10,155 | 10.6% | $198.81 | — | — | 04351P101 |
| LENZ | LENZ THERAPEUTICS INC | 175,363 | $8,168 | 8.5% | $27.20 | +7.2% | — | 52635N103 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 437,391 | $5,944 | 6.2% | $9.41 | +44.3% | — | 03237H101 |
| CMPS | COMPASS PATHWAYS PLC | 1,026,382 | $5,881 | 6.1% | $2.80 | — | — | 20451W101 |
| PRAX | PRAXIS PRECISION MEDICINES I | 100,000 | $5,300 | 5.5% | $186.22 | 0.0% | CALL | 74006W207 |
| MNPR | MONOPAR THERAPEUTICS INC | 64,455 | $5,264 | 5.5% | $40.21 | +103.2% | — | 61023L207 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 233,220 | $4,396 | 4.6% | $15.77 | +62.3% | — | 03969K108 |
| — | MIND MEDICINE MINDMED INC | 361,444 | $4,261 | 4.4% | $7.76 | — | — | 60255C885 |
| TARS | TARSUS PHARMACEUTICALS INC | 70,778 | $4,206 | 4.4% | $28.11 | +165.7% | — | 87650L103 |
| — | PROMIS NEUROSCIENCES INC | 6,233,497 | $2,649 | 2.8% | $0.65 | — | — | 74346M406 |
| AVTX | AVALO THERAPEUTICS INC | 178,100 | $2,264 | 2.4% | $8.60 | +96.3% | — | 05338F306 |
| TECX | TECTONIC THERAPEUTIC INC | 138,595 | $2,175 | 2.3% | $30.22 | -38.5% | — | 878972108 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 69,000 | $495 | 0.5% | — | — | CALL | 61559X104 |
| ATYR | ATYR PHARMA INC | 600,000 | $433 | 0.5% | — | — | CALL | 002120202 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | 168,029 (-44.5%) | $7,780 (-62.0%) | 8.1% | $65.05 | -15.7% | COM | 834203309 |
| — | ATAI BECKLEY NV | 1,713,105 (-25.1%) | $7,007 (-42.1%) | 7.3% | $5.29 | — | SHS | N0731H103 |
| TSHA | TAYSHA GENE THERAPIES INC | 457,132 (-75.9%) | $2,514 (-59.5%) | 2.6% | $2.83 | +71.5% | COM SHS | 877619106 |
| REPL | REPLIMUNE GROUP INC | 1,200,000 (-66.7%) | $11,664 (-22.7%) | 12.2% | — | — | CALL | 76029N106 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 397,895 (-56.5%) | $3,004 (-44.4%) | 3.1% | $5.44 | +13.3% | COM | 29842P105 |
| SLDB | SOLID BIOSCIENCES INC | 413,625 (-24.7%) | $2,333 (-31.2%) | 2.4% | $3.54 | +53.3% | COM NEW | 83422E204 |
| CMPS | COMPASS PATHWAYS PLC | 1,100,000 (-4.0%) | $7,590 (+15.6%) | 7.9% | $2.80 | — | CALL | 20451W101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WHWK | WHITEHAWK THERAPEUTICS INC | 817,939 | $1,979 | 2.1% | $2.27 | +1.3% | COM | 00032Q104 |